FAITH CLAUSE: Open Payments
NPI 1093250862 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 81 payments from 25 companies in 2025. Trend: 2023 $2,689 · 2024 $2,620 · 2025 $1,949
Food & beverage: $1,949
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $283 |
| UCB, Inc. | 5 | $153 |
| Alexion Pharmaceuticals, Inc. | 5 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $132 |
| PFIZER INC. | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| MDD US Operations, LLC | 3 | $96 |
| ACADIA Pharmaceuticals Inc | 3 | $91 |
| Lundbeck LLC | 3 | $80 |
Products named: QULIPTA, ULTOMIRIS, HYQVIA, Briviact, NURTEC ODT, REXULTI, KESIMPTA, NUPLAZID.
Industry payments across CA — which companies pay providers there.
